Close Menu

NEW YORK – The Parkinson's Foundation has launched a nationwide genetics project that will analyze potential biomarkers for Parkinson's disease (PD) to improve clinical care and offer new treatment options for patients. Called PD GENEration: Mapping the Future of Parkinson's Disease, the initiative will include sequencing efforts from Fulgent Genetics and database management support from several academic institutions.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.